- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04533100
The Association of Protein-Energy Adequacy With Mortality in Critically Ill Patients With Acute Kidney Injury.
The Association of Protein-Energy Adequacy With Mortality in Critically Ill Patients With Acute Kidney Injury. A Prospective Observational Single- Centre Study.
Study Overview
Status
Conditions
Detailed Description
Patients with Acute Kidney Injury, AKI are probably more exposed to the risk of malnutrition especially if they undergo Renal Replacement Therapy, RRT. Optimization of nutrients especially energy and protein can ensure a better health outcome for critically ill patients with AKI. Moreover, there is no research on the association of Protein- Energy adequacy with mortality among critically ill patients with AKI in Malaysia. So, the main purpose of this study is to investigate the relationship of Protein-Energy adequacy with mortality among critically ill patients with AKI
Subjects will be recruited upon admission in ICU after fulfilling the inclusion and exclusion criteria. They will be follow up from day 1 until day 14 or until ICU Discharge. Data including Demographic, Clinical, Laboratory, and Nutritional Status will be recorded. On Day 28, the outcome data including Mortality, length of ICU Stay, and Length of Ventilator day will be recorded.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: MOHD SHAHNAZ HASAN, MBBS
- Phone Number: 3869 0379493869
- Email: shahnaz@ummc.edu.my
Study Contact Backup
- Name: MOHAMAD IRFAN OTHMAN JAILANI, DIETETICS
- Phone Number: 3869 0379493869
- Email: mioj92@gmail.com
Study Locations
-
-
-
Kuala Lumpur, Malaysia, 59100
- Recruiting
- University Malaya Medical Centre
-
Contact:
- MOHD SHAHNAZ HASAN, MBBS
- Phone Number: 3869 0379493869
- Email: shahnaz@ummc.edu.my
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who are 18 years old and older
- Patients who are admitted to the participating ICU.
- Patients who are mechanically ventilated.
Exclusion Criteria:
- Patients who are less than 18 years old
- End-stage renal disease patients
- Patients undergo kidney transplantation within 3 months before ICU admission
- Pregnant patients
- The patient is moribund with expected death within 24 hour or whom survival to 28 days is unlikely due to uncontrollable comorbidity (cardiac, pulmonary or hepatic end-stage disease; hepatorenal syndrome; poorly controlled cancer; severe post-anoxic encephalopathy and others)
- Prior treatment with RRT within 30 days
- Anticipated alive ICU discharge within 24 hours
- Readmission to the ICU during the same hospitalization episode.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
28-Days Mortality
Time Frame: 1 day
|
Mortality status of subjects on day 28 from recruitment.
|
1 day
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Length of ICU Stay
Time Frame: 1 day
|
Duration of ICU Stay from ICU admission until ICU discharge
|
1 day
|
Length of Ventilator Day
Time Frame: 1 day
|
Duration of ventilator used by subjects from ICU admission until ICU discharge
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: MOHD SHAHNAZ HASAN, MBBS, University of Malaya
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- MREC ID NO: 2018222-6043
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
University Hospital Birmingham NHS Foundation TrustCompletedRehabilitation After Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance